TERRANET
Following the launch at CES in Las Vegas 2020, Terranet has through Q1 up to now taken further important steps in the development and proof of concept cycle with the life saving 3D motion software technology – Voxelflow. "With higher accuracy, lower latency at higher resolution we are coming closer to a point what no human eye or computer vision system has ever been capable of achieving," says Terranet CEO Pär-Olof Johannesson.
Terranet’s vision is to contribute to the future realisation of the policy formulated by the third global ministerial conference on road safety in Stockholm in February 2020 that requires that fatalities and serious injuries are reduced in half by 2030. In our mission to carry out this vision, Voxelflow will also greatly enhance the mobility services and autonomous systems capabilities on collision warning and mitigation.
Based on recent findings and progress, way forward, Terranet’s strategy is to field test the technology by setting up demo vehicle platforms and test beds in close collaboration with OEM car manufacturers and Tier-1 component suppliers of active safety systems. This will be arrived at through a gradual industrialization and customer centric product development process. The present prototype including camera hardware will gradually be miniaturised to sensors which will be mounted in windshields and headlamps as part of future generations of advanced-driver-assisted-systems (ADAS) offerings for semi and fully autonomous cars.
Invented by Dirk Smits, now Terranet CTO, VoxelFlow was built upon the understanding that today’s camera-based computer vision and artificial intelligence navigation systems are simply too slow and subject to fundamental speed limits of perception using a frame based approach. Lidar has limited resolution and slow scanning rates, making it nearly impossible to distinguish between, for example, a fixed lamppost and a running child.
VoxelFlow’s capabilities are especially relevant considering harrowing statistics indicating that 80% of all crashes and 65% of all near-crashes involve driver inattention within the last 3 seconds of the crash. By providing life-saving decision making in milliseconds versus seconds, Terranet envisions transforming the pre-crash inattention that today accounts for roughly 1.35M road accident deaths into a forgotten collision-free swerve on the road.
Comparing the COVID-19 pandemic to car accidents is misguided and sets a false equivalency. However, yet approximately 1,35 perished in traffic last year according to WHO. That is 3700 road-deaths on average worldwide, everyday. It translates to seven fully occupied Airbus 380 crashing everyday without survivors. Road traffic crashes cost most countries 3% of their gross domestic product. Road traffic injuries are the leading cause of death for children and young adults aged 5-29 years. The horrible statistics on road-deaths is a matter of fact. While a virus is unpredictable, traffic casualties are predictable, and preventable. Terranet remains committed to pursue its vision, purpose and dedication to decrease fatal accidents through the exploration and discovery of new features related to Voxelflow - the life saving 3D motion software.
"We are seeing an advent of a paradigm shift where future holds a more conscientious community where progressive innovations on ADAS-technologies thrive and make the difference of life and death, in favor of design, horsepower and look and feel. It's time to embark upon this life-saving ride. We can fix what is what is broken with a novel technology and 3D motion perception software called Voxelflow," says Terranet CEO, Pär-Olof Johannesson.
ABOUT TERRANET
Terranet design radio and 3D vision based ADAS software platforms for collision avoidance.
https://vimeo.com/408757482
Terranet is headquartered in Lund, Sweden, with offices in Stuttgart and California.
Terranet Holding AB (publ) is listed on Nasdaq First North Premier in Stockholm.
Mangold Fondkommission AB - an independent securities services broker on Nasdaq is assigned as Terranet’s bookrunner on future share rights issues.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200425005006/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
SBC Medical added to membership of Russell 3000® Index28.6.2025 01:30:00 CEST | Press release
SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“SBC Medical”), a global franchise and provider of services for aesthetic clinics, has been added as a member of the broad-market Russell 3000® Index, effective after the US market opens on June 30, as part of the 2025 Russell indexes reconstitution. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250608244276/en/ Yoshiyuki Aikawa-Director (Chairman), CEO Membership in the Russell 3000® Index, which remains in place for one year, means automatic inclusion in the large-cap Russell 1000® Index or small-cap Russell 2000®Index as well as the appropriate growth and value style indexes. Russell indexes are widely used by investment managers and institutional investors for index funds and as benchmarks for active investment strategies. According to the data as of the end of June 2024, about $10.6 trillion in assets are benchmarked against the Russell US indexes, which belong to
Altimetrik and SLK Software Join Forces to Create an AI-First Engineering Services Powerhouse27.6.2025 22:44:00 CEST | Press release
Altimetrik, a pure-play AI, Data and Digital engineering solutions company, today announced the signing of a definitive agreement to acquire SLK Software (“SLK”), a global technology services firm focused on delivering AI, intelligence automation and analytics solutions. The acquisition will further strengthen Altimetrik’s end-to-end enablement services and expand its customer reach, with a clear path to accelerate towards Altimetrik’s goal of reaching $1billion in annual revenue. The transaction remains subject to customary closing conditions and is expected to close in the second half of 2025. Financial details were not disclosed. Founded in 2000, SLK is recognized as a leader in the tech industry, and for its commitment to create innovative digital solutions. This strategic acquisition will significantly enhance the scale of Altimetrik’s capabilities, bringing together Altimetrik’s AI-first, platform-native engineering model and SLK’s full technology services stack that will further
Andersen Consulting udvider sine kompetencer inden for forretningstransformation med tilføjelsen af The Clearing27.6.2025 16:48:00 CEST | Pressemeddelelse
Andersen Consulting udbygger sin platform med samarbejdsfirmaet The Clearing, som er en managementkonsulentvirksomhed med speciale i organisatorisk omstilling og lederudvikling. The Clearing blev stiftet i 2009 og rådgiver kunder om komplekse udfordringer ved at afstemme ledelse, strategi, kultur og drift. Firmaet arbejder med føderale agenturer, virksomheder og nonprofitorganisationer med henblik på at skabe målbare forandringer på tværs af forskellige interessenter til gavn for en leders vision og strategi. Med dyb erfaring inden for flere sektorer, herunder national sikkerhed, sundhedspleje og finansielle tjenester, leder The Clearings unikke blanding af talent med ekspertise inden for organisationsudvikling, dataanalyse og visuel rådgivning forretningstransformationer i stor skala og arbejder sammen med kunder og eksperter for at sikre, at rådgivning omsættes til implementering. "Vi leverer transformative resultater, der ikke kun er i overensstemmelse med strategiske mål, men også
PRD Therapeutics Announces Initiation of First-in-Human Study for PRD00127.6.2025 16:00:00 CEST | Press release
PRD Therapeutics, Inc., a clinical stage company focused on the development of novel lipid metabolism regulators targeting homozygous familial hypercholesterolemia (HoFH) and metabolic dysfunction associated fatty liver disease (MASH/MASLD), today announced that the company recently initiated dosing in a First-in-Human (FIH) clinical trial of PRD001, a first-in-class SOAT2 (formerly known as ACAT2) selective inhibitor. “We are excited to initiate dosing in this clinical trial of PRD001. Many clinical trials have been conducted on SOAT1/2 dual or SOAT1 selective inhibitors, but this is the first clinical trial of an SOAT2 selective inhibitor” said Kanji Hosoda, Ph.D., CEO and co-founder of PRD Therapeutics. “Several results with SOAT1 or 2 knockout mice have been published, suggesting that knocking out or inhibiting only SOAT2 is crucial to demonstrate safety and efficacy. PRD001 is the world's first and only SOAT2-selective inhibitor and is expected to exhibit safety and efficacy in hu
STEMCELL Technologies Introduces STEMprep™ Tissue Dissociator System to Accelerate Research Discoveries27.6.2025 14:00:00 CEST | Press release
New instrument automates tissue processing for researchers in cancer, immunology and other science fields To help scientists accelerate their workflows, STEMCELL Technologies has commercially launched the STEMprep™ Tissue Dissociator System—a new benchtop instrument that automates, standardizes, and streamlines tissue dissociation, the process of breaking down tissue samples into single-cell suspensions for research purposes. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250627342791/en/ To help scientists accelerate their workflows, STEMCELL Technologies has commercially launched the STEMprep™ Tissue Dissociator System—a new benchtop instrument that automates, standardizes, and streamlines tissue dissociation, the process of breaking down tissue samples into single-cell suspensions for research purposes. “Tissue dissociation is incredibly important for making advancements in research fields, like cancer and immunology, yet
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom